LY-294002 hydrochloride is a derivative of the flavonoid, quercetin and elicits higher inhibition on the enzyme phosphoinositide 3-kinase (PI3K).

GSK2636771 is a potent, orally bioavailable and selective inhibitor of PI3Kβ.

PF-04691502 is an ATP-competitive PI3K(α/β/δ/γ)/mTOR dual inhibitor.

Akti-1/2 is a highly selective Akt1/Akt2 inhibitor.

LY294002 is the first synthetic specific inhibitor of phosphatidylinositol 3-kinase.

Tacrolimus, a macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis, is a Calcineurin Inhibitor Immunosuppressant.

Rapamycin, a macrolide compound obtained from Streptomyces hygroscopicus, is aa mTOR Inhibitor Immunosuppressant and Kinase Inhibitor.

Idelalisib is Kinase Inhibitor, and Cytochrome P450 3A Inhibitor.